MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cognitive impairment profile of patients with Essential Tremor and Parkinson’s Disease

A. Abundes-Corona, A. Cervantes-Arriaga, R. Zerón-Martínez, R. Solís-Vivanco, O. Cárdenas-Saenz, M. Rodríguez-Violante (Mexico City, Mexico)

Meeting: 2019 International Congress

Abstract Number: 1652

Keywords: Cognitive dysfunction, Essential tremor(ET), Parkinsonism

Session Information

Date: Wednesday, September 25, 2019

Session Title: Cognition and Cognitive Disorders

Session Time: 1:15pm-2:45pm

Location: Agora 3 East, Level 3

Objective: To identify if the Montreal Cognitive Assessment (MoCA) is a sensible tool to differentiate cognitive impairment profiles between patients with Essential Tremor (ET) and Parkinson’s disease (PD).

Background: Cognitive decline has been widely recognized in patients with Parkinson’s disease and is subject of recent interest in Essential Tremor.  The very distinct pathophysiology of both conditions imply different mechanisms of cognitive impairment and this is frequently recognized in the clinical practice. Essential Tremor, long thought to be a mono-symptomatic disease, is now recognized as a heterogeneous condition that affects multiple cerebral functions such as mood and cognition which remain highly underdiagnosed.  Domains particularly affected in ET are those that rely on the integrity of the prefrontal cortex, which suggests involvement of frontocerebellar circuits in this disease. On the other hand PD patients are described as impaired in the attention/executive functions, memory, and visuospatial skills.

Method: 124 patients, 44 with ET and 80 with PD (mean age 62.8±13 65% female) were recruited form our previous cohort. MoCA Spanish version (MoCA SP) was used to screen for cognitive impairment (mean score 22.1 +/- 4.6). Years of education were taken into account to adjust for the recognition of cognitive impairment (mean 10.6 years ±5.2.) Cognition subdomains were categorized as follows: visuospatial/executive, attention, language, abstraction, delayed recall and orientation. Each domain was analyzed individually and then compared between groups.

Results: As expected, there was a high proportion of patients with any degree of cognitive impairment (MoCA-SP ≤25): 75% of the PD patients and 81.1% of the ET patients had a positive screening test for cognitive decline (p= .385). Both groups had subpar scores in the visuospatial/executive (p= .267), attention (p= .702) and delayed recall (p= .593) subdomains, without statistically significant differences among them. The abstraction subdomain, though impaired in both groups, was more affected in ET patients (p. <.0001).

Conclusion: Though we confirmed a high prevalence of cognitive decline in patients with PD and ET, no significant differences were relevant in this initial screening study. The limitations of MoCA-SP mandate further, more profound neuropsychological testing to better categorize the cognitive profiles of both groups.

References: 1. Azar, M., Bertrand, E., Louis, E. D., Huey, E., Collins, K., Rohl, B., & Cosentino, S. (2017). Awareness of cognitive impairment in individuals with essential tremor. Journal of the Neurological Sciences, 377, 155-160. Retrieved February 28, 2019, from 10.1016/j.jns.2017.04.009 2. Bain, P. (2005). The Clinical Assessment of Essential Tremor, 93-115. Retrieved February 28, 2019, from 10.1201/b14115-9. 3. Bermejo-Pareja, F. (2011). Essential tremor—a neurodegenerative disorder associated with cognitive defects?. Nat Rev Neurol, 7(5), 273-282. Retrieved February 28, 2019, from 10.1038/nrneurol.2011.44 4. Duane, D. D., Vermilion, K. J., Lombardi, W., Woolston, D., Roberts, J., & Gross, R. (2002). Cognitive deficits in patients with essential tremor. Neurology, 58(11), 1706-1707. Retrieved February 28, 2019, from 10.1212/wnl.58.11.1706 5. Dwolatzky, T. (2011). Cognitive Impairment and Dementia in Parkinson Disease. JAMA, 305(21), 2231. Retrieved February 28, 2019, from 10.1001/jama.2011.732 6. Goldman, J. G., Vernaleo, B. A., Camicioli, R., Dahodwala, N., Dobkin, R. D., Ellis, T., Galvin, J. E., Marras, C., Edwards, J., & Fields, J. (2018). Cognitive impairment in Parkinson’s disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health. npj Parkinson’s Disease, 4(1). Retrieved February 28, 2019, from 10.1038/s41531-018-0055-3 7. Jellinger, K. A. (2013). Mild cognitive impairment in Parkinson disease: heterogenous mechanisms. J Neural Transm, 120(1), 157-167. Retrieved February 28, 2019, from 10.1007/s00702-012-0771-5 8. Schnitzler, A., & Wojtecki, L. (2011). Faculty of 1000 evaluation for Altered cortical-cerebellar circuits during verbal working memory in essential tremor. Retrieved February 28, 2019, from 10.3410/f.13221956.14568054

To cite this abstract in AMA style:

A. Abundes-Corona, A. Cervantes-Arriaga, R. Zerón-Martínez, R. Solís-Vivanco, O. Cárdenas-Saenz, M. Rodríguez-Violante. Cognitive impairment profile of patients with Essential Tremor and Parkinson’s Disease [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/cognitive-impairment-profile-of-patients-with-essential-tremor-and-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/cognitive-impairment-profile-of-patients-with-essential-tremor-and-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley